-
Forward Look
Speeding Up Multiple Myeloma Drug DevelopmentHematologist-oncologist C. Ola Landgren explains how measuring minimal residual disease could be useful in multiple myeloma clinical trials.
by Anna Azvolinsky
-
From the Editor-in-Chief
A New Treatment for Some Brain TumorsA recently approved therapy targets abnormal enzymes produced by gene defects.
by William G. Nelson, MD, PhD
-
Forward Look
Stem Cell Transplant Rates Decrease for LymphomaMore patients are receiving CAR T-cell therapy for large B-cell lymphoma.
by Leah Lawrence
-
Forward Look
Mobilizing an Immune Response in Metastatic Prostate CancerA new approach that uses a probe to freeze tumor cells followed by an infusion of immune-boosting drugs shows promising results in an early clinical trial.
-
Forward Look
Ushering in a New Standard of CareTargeted therapy extends progression-free survival in people with stage III EGFR-mutated lung cancer.
by Darcy Lewis
-
Making Their MarkWith targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
by Kendall K. Morgan
-
Survivor Profile
A Cause for ConcernMargie Wilson is helping Black women understand their risk for endometrial cancer and teaching them not to ignore the warning signs.
by Taayoo Murray
-
Healthy Habits
Plant PowerPlant-based diets may help people with prostate cancer reduce their risk for disease progression.
by Anne Danahy
-
Forward Look
Cognition and Prostate CancerAndrogen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
by Joseph Jalkiewicz
-
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
